← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2015Last known activity
Nov 25, 2020
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT04641481Overall official - principal investigatorPhase 3Nov 25, 2020
- NCT03004196Overall official - principal investigatorPhase 1/Phase 2Sep 1, 2015
- NCT03004196Reponsible party - principal investigatorPhase 1/Phase 2Sep 1, 2015
- NCT03004196Lead sponsorPhase 1/Phase 2Sep 1, 2015
- NCT02357771CollaboratorPhase 3Apr 1, 2015
Details
- Last known activity
- Nov 25, 2020